In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Deciphera goes public, nets $129mm through IPO

Executive Summary

Deciphera Pharmaceuticals Inc. (developing small-molecule cancer therapies) netted $129mm through its initial public offering of 8.17mm common shares (including partial exercise of the overallotment) at $17. The company had originally hoped to sell 6.25mm common shares for between $15-17 apiece when it filed earlier this month.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

Advertisement
UsernamePublicRestriction

Register